STOCK TITAN

IBM (IBM) awards RSUs and stock options to Senior Vice President Lamoreaux

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

LAMOREAUX NICKLE JACLYN reported acquisition or exercise transactions in this Form 4 filing.

INTERNATIONAL BUSINESS MACHINES CORP reported that Senior Vice President Nickle Jaclyn Lamoreaux received new equity-based compensation. On February 26, 2026, she was granted 6,285 restricted stock units at a stated price of $0.00 per unit and 25,138 employee stock options at $0.00 per option.

The restricted stock units are scheduled to lapse in stages, with 1,571 units each becoming payable on February 26, 2027, February 26, 2028, and February 26, 2029, and 1,572 units on February 26, 2030, payable in cash or IBM common stock. The employee stock options vest in four equal annual installments starting on the first exercisable date and expire on the expiration date specified in the award terms.

Positive

  • None.

Negative

  • None.

Insights

Routine IBM executive equity grants with multi‑year vesting schedule.

IBM granted Senior Vice President Nickle Jaclyn Lamoreaux 6,285 restricted stock units and 25,138 employee stock options on February 26, 2026. Both awards carry a stated grant price of $0.00, consistent with standard equity compensation where value comes from future share price and vesting.

The RSUs vest in four annual tranches from 2027 through 2030 and may settle in cash or common stock, while the options vest in four equal annual installments and remain exercisable until their stated expiration date. This structure is typical for long-term incentive plans and is not, by itself, a directional signal on IBM’s near-term performance.

Insider LAMOREAUX NICKLE JACLYN
Role Senior Vice President
Type Security Shares Price Value
Grant/Award Rst. Stock Unit 6,285 $0.00 --
Grant/Award Emp. Stock Option (right to buy) 25,138 $0.00 --
Holdings After Transaction: Rst. Stock Unit — 6,285 shares (Direct); Emp. Stock Option (right to buy) — 25,138 shares (Direct)
Footnotes (1)
  1. Upon lapse of the restrictions, these units are payable in cash or the company's common stock. The restrictions lapse for 1,571 of these units on February 26, 2027, 1,571 of these units on February 26, 2028, 1,571 of these units on February 26, 2029, and 1,572 of these units on February 26, 2030. These derivative securities vest in four equal annual installments, the first vesting being on the date exercisable shown. All expire on the expiration date shown above.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LAMOREAUX NICKLE JACLYN

(Last) (First) (Middle)
IBM CORPORATION
ONE NEW ORCHARD ROAD

(Street)
ARMONK NY 10504

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INTERNATIONAL BUSINESS MACHINES CORP [ IBM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Senior Vice President
3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Rst. Stock Unit $0.00(1) 02/26/2026 A(1) 6,285 (1) (1) Common Stock 6,285 $0.00 6,285 D
Emp. Stock Option (right to buy) $243.22 02/26/2026 A 25,138 02/26/2027(2) 02/25/2036(2) Common Stock 25,138 $0.00 25,138 D
Explanation of Responses:
1. Upon lapse of the restrictions, these units are payable in cash or the company's common stock. The restrictions lapse for 1,571 of these units on February 26, 2027, 1,571 of these units on February 26, 2028, 1,571 of these units on February 26, 2029, and 1,572 of these units on February 26, 2030.
2. These derivative securities vest in four equal annual installments, the first vesting being on the date exercisable shown. All expire on the expiration date shown above.
Remarks:
L. Mallardi on behalf of N. J. LaMoreaux 02/27/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did IBM (IBM) grant to Nickle Jaclyn Lamoreaux?

IBM granted Senior Vice President Nickle Jaclyn Lamoreaux 6,285 restricted stock units and 25,138 employee stock options on February 26, 2026. Both awards were recorded at a grant price of $0.00, reflecting standard equity compensation rather than a cash purchase in the market.

How do the new IBM restricted stock units for Lamoreaux vest?

The 6,285 IBM restricted stock units vest in four annual tranches. 1,571 units each lapse on February 26, 2027, 2028, and 2029, and 1,572 units on February 26, 2030. Upon each lapse, the units are payable in either cash or IBM common stock.

What is the vesting schedule for the IBM stock options granted to Lamoreaux?

The 25,138 IBM employee stock options vest in four equal annual installments. The first portion vests on the initial exercisable date, with remaining installments each year thereafter. All of these options expire on the specific expiration date defined in the award documentation.

Does the IBM Form 4 show Lamoreaux buying or selling IBM shares?

The Form 4 shows equity awards being acquired, not open-market buying or selling. Lamoreaux received restricted stock units and stock options as a grant, coded as an acquisition (A), representing compensation rather than a discretionary purchase or sale of IBM shares.

Can the IBM restricted stock units granted to Lamoreaux be settled in shares?

Yes. Upon each vesting date, the IBM restricted stock units are payable in either cash or the company’s common stock. The specific settlement form is determined under the plan terms, but the filing explicitly allows for payment in IBM common shares or cash.

How many IBM derivative securities will Lamoreaux hold after these grants?

After the grants, Lamoreaux will hold 6,285 restricted stock units and 25,138 employee stock options, according to the reported post-transaction totals. These figures represent her direct holdings of these specific derivative awards as of the grant date in the Form 4.